Asunto(s)
Bevacizumab , Hemorragia Gastrointestinal , Humanos , Hemorragia Gastrointestinal/inducido químicamente , Hemorragia Gastrointestinal/etiología , Bevacizumab/efectos adversos , Bevacizumab/uso terapéutico , Masculino , Inhibidores de la Angiogénesis/efectos adversos , Inhibidores de la Angiogénesis/uso terapéutico , Anciano , Hemostasis/efectos de los fármacos , Linfoma/tratamiento farmacológico , Linfoma/complicaciones , Femenino , Persona de Mediana EdadAsunto(s)
Hemostasis , Trombosis , Hemostasis/fisiología , Humanos , Sociedades Médicas , Alemania , Investigación BiomédicaRESUMEN
BACKGROUND: Nephrotic syndrome (NS) is associated with a high risk of thrombotic complications. In this group of patients, routine local tests for assessing hemostasis do not accurately reflect hypercoagulable state. Global functional tests for assessing hemostasis, including thrombodynamics (TD), are considered promising for assessing disorders in the blood coagulation system of these patients. AIM: To compare the rate of hypercoagulability according to routine hemostatic tests and TD and to evaluate the factors associated with increased risk of thrombotic complications in patients with chronic glomerulonephritis (CGN). MATERIALS AND METHODS: The study included 94 patients with active CGN who were not receiving anticoagulant therapy; 63 (80.3%) patients had NS, and 31 (19.7%) had active CGN without NS. Hemostasis parameters were assessed using local coagulation tests and TD test. Using logistic regression analysis, factors associated with the risk of thrombosis were assessed. RESULTS: Of the 94 patients with active CGN in 63 without preventive anticoagulant therapy, hypercoagulability according to routine tests was detected in 6 (9.5%) patients with NS and in 3 (9.7%) patients without NS (p<0.05). Hypercoagulability according to the TD test was detected in 24 (53.9%) patients with NS and in 5 (32.2%) without NS (p<0.05). The formation of spontaneous clots was observed in 29 (30.9%) of patients with CGN, most of them 24 (83%) with NS. 10.6% of patients in our cohort experienced thromboembolic events. The risk of thromboembolic events according to the univariate regression analysis was associated with older age, higher lipid levels, use of glucocorticosteroids and detection of spontaneous clots by the TD test. No association of thromboembolic events with abnormalities in routine hemostasis tests was obtained. CONCLUSION: In patients with CGN with nephrotic syndrome, hypercoagulability is detected in 9.5% of cases with routine coagulation tests and in 53.9% of cases with TD test. Detection of spontaneous clots by TD test is associated with a risk of thromboembolic events.
Asunto(s)
Glomerulonefritis , Trombofilia , Humanos , Masculino , Femenino , Trombofilia/sangre , Trombofilia/diagnóstico , Trombofilia/etiología , Glomerulonefritis/sangre , Glomerulonefritis/complicaciones , Glomerulonefritis/diagnóstico , Adulto , Persona de Mediana Edad , Pruebas de Coagulación Sanguínea/métodos , Hemostasis/fisiología , Enfermedad Crónica , Síndrome Nefrótico/complicaciones , Síndrome Nefrótico/sangre , Síndrome Nefrótico/diagnósticoRESUMEN
Tumor cells can survive when detached from the extracellular matrix (ECM) or lose cell-cell connections, a phenomenon known as anoikis-resistance (AR). AR is closely associated with tumor cell metastasis and recurrence, enabling tumor cells to disseminate, migrate, and invade after detachment. To address this issue, a novel intervention method combining intraoperative hemostasis with multifunctional nanozyme driven-enhanced chemodynamic therapy (ECDT) has been proposed, which holds the potential to weaken the AR capability of tumor cells and suppress tumor recurrence. Here, a nanocomposite containing a dendritic mesoporous nanoframework with Cu2+ was developed using an anion-assisted approach after surface PEG grafting and glucose oxidase (GOx) anchoring (DMSN-Cu@GOx/PEG). DMSN-Cu@GOx/PEG was further encapsulated in a thermal-sensitive hydrogel (H@DMSN-Cu@GOx/PEG). DMSN-Cu@GOx/PEG utilizes its high peroxidase (POD) activity to elevate intracellular ROS levels, thereby weakening the AR capability of bladder cancer cells. Additionally, through its excellent catalase (CAT) activity, DMSN-Cu@GOx/PEG converts the high level of hydrogen peroxide (H2O2) catalyzed by intracellular GOx into oxygen (O2), effectively alleviating tumor hypoxia, downregulating hypoxia-inducible factor-1α (HIF-1α) expression, inhibiting epithelial-mesenchymal transition (EMT) processes, and ultimately suppressing the migration and invasion of bladder cancer cells. Interestingly, in vivo results showed that the thermosensitive hydrogel H@DMSN-Cu@GOx/PEG could rapidly gel at body temperature, forming a gel film on wounds to eliminate residual tumor tissue after tumor resection surgery. Importantly, H@DMSN-Cu@GOx/PEG exhibited excellent hemostatic capabilities, effectively enhancing tissue coagulation during post-tumor resection surgery and mitigating the risk of cancer cell dissemination and recurrence due to surgical bleeding. Such hydrogels undoubtedly possess strong surgical application. Our developed novel nanosystem and hydrogel can inhibit the AR capability of tumor cells and prevent recurrence post-surgery. This study represents the first report of using dendritic mesoporous silica-based nanoreactors for inhibiting the AR capability of bladder cancer cells and suppressing tumor recurrence post-surgery, providing a new avenue for developing strategies to impede tumor recurrence after surgery.
Asunto(s)
Glucosa Oxidasa , Hidrogeles , Hidrogeles/química , Hidrogeles/farmacología , Animales , Humanos , Línea Celular Tumoral , Ratones , Glucosa Oxidasa/farmacología , Glucosa Oxidasa/metabolismo , Glucosa Oxidasa/química , Recurrencia Local de Neoplasia , Ratones Desnudos , Ratones Endogámicos BALB C , Nanocompuestos/química , Nanocompuestos/uso terapéutico , Polietilenglicoles/química , Polietilenglicoles/farmacología , Especies Reactivas de Oxígeno/metabolismo , Cobre/química , Cobre/farmacología , Hemostasis/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Peróxido de Hidrógeno/farmacologíaRESUMEN
Introduction: Elevated ambient pollution exposure is potentially linked to thromboembolism. However, the mechanisms by which particulate matter (PM) interferes with the balance of hemostatic system remain unclear. This study investigates PM-mediated hemostatic changes in individuals across unique seasonal variations of ambient pollution. Methods: This prospective study was conducted between February and July 2020 during alterations in ambient pollution in Chiang Mai, Thailand. Blood tests from 30 healthy subjects were assessed at four-week intervals, four times in total. Various coagulation tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), von Willebrand factor (vWF), platelet count, and platelet functions, were evaluated. A mixed-effects model was used to analyze the impact of high PM2.5 and PM10 on hemostatic parameters. Results: Thirty male subjects with mean age of 38.9 ± 8.2 years, were included. High levels of PM2.5 and PM10 were significantly associated with PT shortening, with no such effect observed in aPTT. PM2.5 and PM10 values also positively correlated with vWF function, while vWF antigen levels remained unchanged. Soluble P-selectin showed a strong positive association with PM2.5 and PM10 levels. Platelet function analysis revealed no correlation with PM values. Conclusion: Short-term exposure to elevated PM2.5 and PM10 concentrations was linked to shortened PT and enhanced vWF function in healthy individuals. Exploring the impact of these changes on clinically relevant thrombosis is crucial. Additional studies on the pathogenesis of pollution-related thrombosis are warranted for maintaining good health.
Asunto(s)
Contaminación del Aire , Plaquetas , Hemostasis , Material Particulado , Humanos , Material Particulado/efectos adversos , Masculino , Adulto , Hemostasis/efectos de los fármacos , Tailandia , Estudios Prospectivos , Contaminación del Aire/efectos adversos , Plaquetas/efectos de los fármacos , Contaminantes Atmosféricos/efectos adversos , Persona de Mediana Edad , Factor de von Willebrand/metabolismo , Factor de von Willebrand/análisis , Recuento de Plaquetas , Exposición a Riesgos Ambientales/efectos adversos , Estaciones del Año , Pruebas de Coagulación SanguíneaRESUMEN
The key to saving lives is to achieve instant and effective sealing hemostasis in the event of emergency bleeding. Herein, a plant oil-based EMTA/Zn2+ bioadhesive is prepared by a facile reaction of epoxidized soybean oil (ESO) with methacrylic acid (MAA) and tannic acid (TA), followed by the addition of zinc ions for coordination with TA. The EMTA/Zn2+ bioadhesive can be rapidly cured in situ at the wound site through photo-cross-linking under ultraviolet (UV) light-emitting diode (LED) irradiation within 30 s, achieving ultrastrong wet-tissue adhesion performance of 92.4 and 51.8 kPa to porcine skin and aortic skin after 7 days underwater, respectively. Especially, the EMTA/Zn2+ bioadhesive exhibits outstanding sealing performance in vitro with the high burst pressure of 525 mmHg (70 kPa) and 337.5 mmHg (45 kPa) to porcine skin and aortic skin, respectively. Moreover, the EMTA/Zn2+ bioadhesive not only has outstanding hemocompatibility and good biodegradability but also exhibits excellent cytocompatibility and antibacterial properties. Notably, the EMTA/Zn2+ bioadhesive has remarkable instant sealing hemostatic ability for hemorrhaging liver in vivo. Therefore, the prepared plant oil-based EMTA/Zn2+ bioadhesive can serve as a charming alternative candidate for instant sealing hemostasis in clinical applications, especially in traumatic internal organs and arterial bleeding.
Asunto(s)
Hemostasis , Animales , Porcinos , Hemostasis/efectos de los fármacos , Aceites de Plantas/química , Aceites de Plantas/farmacología , Hemostáticos/química , Hemostáticos/farmacología , Adhesivos Tisulares/química , Adhesivos Tisulares/farmacología , Zinc/química , Zinc/farmacología , Ratones , Humanos , Hemorragia/tratamiento farmacológico , Piel/efectos de los fármacos , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Taninos/química , Taninos/farmacología , Metacrilatos/química , Metacrilatos/farmacologíaRESUMEN
The Helicobacter pylori infection in the stomach is the key reason for gastric mucosal bleeding. Eliminating gastric Helicobacter pylori by oral treatment remains difficult due to the presence of the gastric mucosal layer, which acts as a physical barrier to drugs via oral administration. In this study, a magnetic-navigable microneedle drug delivery platform (MNsD) for oral administration, featuring differential dual-mode drug release rate, was designed to fulfil rapid gastric hemostasis and overcome the gastric barriers for long-lasting Helicobacter pylori inhibition in stomach. MNs-D was created by rationally loading the carrier substrate, which was composed of silk fibroin with variable solubility, with antibiotics and hemostats. In vitro experiments showed MNs-D may sustainably eradicate Helicobacter pylori in stimulated gastric juices with long-lasting drug release (79 % in 24 h) and quickly establish hemostasis with instant drug release (92 % within 60 s). Most importantly, in vivo studies demonstrated MNs-D overcame the unsettling gastric mucosal barrier in traditional therapies of oral administration by insertion into the GML under magnetic navigation, resulting in sustained antibiotic release for long-lasting Helicobacter pylori eradiation (99 %). For differential dual-mode medication release against gastric Helicobacter pylori infections, this study may have firstly examined the effects of magnetic navigated microneedles administered orally.
Asunto(s)
Antibacterianos , Sistemas de Liberación de Medicamentos , Fibroínas , Mucosa Gástrica , Infecciones por Helicobacter , Helicobacter pylori , Agujas , Helicobacter pylori/efectos de los fármacos , Animales , Fibroínas/química , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/microbiología , Administración Oral , Antibacterianos/farmacología , Antibacterianos/administración & dosificación , Antibacterianos/farmacocinética , Antibacterianos/química , Mucosa Gástrica/metabolismo , Mucosa Gástrica/microbiología , Mucosa Gástrica/efectos de los fármacos , Liberación de Fármacos , Hemostasis/efectos de los fármacos , Estómago/microbiología , Estómago/efectos de los fármacos , Masculino , RatonesRESUMEN
The development of an effective hemostatic agents is of vital importance for saving wounded individuals from uncontrolled hemorrhage, which is the main reason for preventable death after accidental injury. However, current high-performance hemostatic agents suffer from a cumbersome preparation procedures and poor biocompatibility. Here, we engineered a cellulosic-derived aerogel material by simply controlling the drying process of cellulose regeneration for fast hemostasis. Four different freeze-drying pretreatments were investigated. As compared with the other three, the cellulosic aerogel material prepared without freezing pretreatment exhibited the lowest crystallinity (21.3%) and the highest body fluid absorption capacity (20.3 times that of its own weight) due to its super hierarchical porous structure, which led to an excellent hemostatic performance in vitro blood coagulation (≈100 s). Moreover, the addition of gelatin and diatomite in the material could tune the functional groups and electrostatic properties of the aerogel and further enhance its hemostatic performance. Various characterizations, including X-ray diffraction (XRD), fourier transform infrared spectroscopy (FTIR), X-ray nanocomputed tomography (CT), scanning electron microscopy (SEM), and zeta potential analysis, were carried out to probe the structure-function relationship of the prepared material, and its mechanism of fast hemostasis was thereafter revealed. The results indicate that the developed aerogel is a cost-effective and feasibly scalable hemostatic material suitable for practical use in industry.
Asunto(s)
Celulosa , Hemostasis , Hemostáticos , Celulosa/química , Hemostáticos/química , Hemostáticos/farmacología , Hemostasis/efectos de los fármacos , Porosidad , Animales , Coagulación Sanguínea/efectos de los fármacos , Liofilización , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos X , Humanos , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Gelatina/químicaRESUMEN
BACKGROUND: Critical shortages in the national blood supply have led to a re-evaluation of previously overlooked donor sources for blood products. As a part of that effort, red blood cells collected from therapeutic phlebotomy of donors on testosterone replacement therapy (TRT) have been conditionally approved for transfusion. However, platelets from TRT donors are not currently approved for use due to limited data on effects of supraphysiologic testosterone on recipient safety and platelet function. The objective of this study was to provide a comprehensive profile of phenotype and function in platelets from TRT and control donors. STUDY DESIGN AND METHODS: Platelets in plasma were collected from TRT and control donors (N = 10 per group; age- and sex-matched) and stored at room temperature for 7 days. On storage Day 1 (D1) and Day 7 (D7), platelet products were analyzed for platelet count, metabolic parameters (i.e., glucose, lactate, mitochondrial function), surface receptor expression, aggregation, thrombin generation, and thrombus formation under physiological flow conditions. RESULTS: TRT donor platelets were not significantly different than control donor platelets in terms of count, surface phenotype, metabolic function, ability to aggregate, thrombin generation, or ability to form occlusive thrombus under arterial flow regimes. Both groups were similar to each other by D7, but had significantly lost hemostatic function compared to D1. DISCUSSION: Platelets derived from donors undergoing TRT have similar phenotypic and functional profiles compared to those derived from control donors. This suggests that therapeutic phlebotomy of TRT donors may provide a useful source for platelet products.
Asunto(s)
Donantes de Sangre , Plaquetas , Conservación de la Sangre , Terapia de Reemplazo de Hormonas , Testosterona , Humanos , Testosterona/sangre , Testosterona/farmacología , Plaquetas/efectos de los fármacos , Plaquetas/metabolismo , Masculino , Fenotipo , Persona de Mediana Edad , Adulto , Hemostasis/efectos de los fármacos , FemeninoRESUMEN
Hydrogels, as an emerging biomaterial, have found extensive use in the healing of wounds due to their distinctive physicochemical structure and functional properties. Moreover, hydrogels can be made to match a range of therapeutic requirements for materials used in wound healing through specific functional modifications. This review provides a step-by-step explanation of the processes involved in cutaneous wound healing, including hemostasis, inflammation, proliferation, and reconstitution, along with an investigation of the factors that impact these processes. Furthermore, a thorough analysis is conducted on the various stages of the wound healing process at which functional hydrogels are implemented, including hemostasis, anti-infection measures, encouraging regeneration, scar reduction, and wound monitoring. Next, the latest progress of multifunctional hydrogels for wound healing and the methods to achieve these functions are discussed in depth and categorized for elucidation. Finally, perspectives and challenges associated with the clinical applications of multifunctional hydrogels are discussed.
Asunto(s)
Hidrogeles , Piel , Cicatrización de Heridas , Cicatrización de Heridas/efectos de los fármacos , Hidrogeles/química , Hidrogeles/farmacología , Humanos , Animales , Piel/efectos de los fármacos , Piel/lesiones , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Hemostasis/efectos de los fármacosRESUMEN
In our search for a biocompatible composite hemostatic dressing, we focused on the design of a novel biomaterial composed of two natural biological components, collagen and sodium alginate (SA), cross-linked using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) and oxidized sodium alginate (OSA). We conducted a series of tests to evaluate the physicochemical properties, acute systemic toxicity, skin irritation, intradermal reaction, sensitization, cytotoxicity, and in vivo femoral artery hemorrhage model. The results demonstrated the excellent biocompatibility of the collagen/sodium alginate (C/SA)-based dressings before and after crosslinking. Specifically, the femoral artery hemorrhage model revealed a significantly shortened hemostasis time of 132.5 ± 12.82 s for the EDC/NHS cross-linked dressings compared to the gauze in the blank group (hemostasis time of 251.43 ± 10.69 s). These findings indicated that C/SA-based dressings exhibited both good biocompatibility and a significant hemostatic effect, making them suitable for biomedical applications.
Asunto(s)
Alginatos , Vendajes , Colágeno , Hemostáticos , Alginatos/química , Alginatos/farmacología , Animales , Colágeno/química , Colágeno/farmacología , Hemostáticos/química , Hemostáticos/farmacología , Ratones , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Ensayo de Materiales , Hemorragia/tratamiento farmacológico , Masculino , Ratas , Hemostasis/efectos de los fármacos , Arteria FemoralRESUMEN
Severe traumatic bleeding may lead to extremely high mortality rates, and early intervention to stop bleeding plays as a critical role in saving lives. However, rapid hemostasis in deep non-compressible trauma using a highly water-absorbent hydrogel, combined with strong tissue adhesion and bionic procoagulant mechanism, remains a challenge. In this study, a DNA hydrogel (DNAgel) network composed of natural nucleic acids with rapid water absorption, high swelling and instant tissue adhesion is reported, like a band-aid to physically stop bleeding. The excellent swelling behavior and robust mechanical performance, meanwhile, enable the DNAgel band-aid to fill the defect cavity and exert pressure on the bleeding vessels, thereby achieving compression hemostasis for deep tissue bleeding sites. The neutrophil extracellular traps (NETs)-inspired DNAgel network also acts as an artificial DNA scaffold for erythrocytes to adhere and aggregate, and activates platelets, promoting coagulation cascade in a bionic way. The DNAgel achieves lower blood loss than commercial gelatin sponge (GS) in male rat trauma models. In vivo evaluation in a full-thickness skin incision model also demonstrates the ability of DNAgel for promoting wound healing. Overall, the DNAgel band-aid with great hemostatic capacity is a promising candidate for rapid hemostasis and wound healing.
Asunto(s)
ADN , Trampas Extracelulares , Hemostasis , Hemostáticos , Hidrogeles , Cicatrización de Heridas , Animales , Trampas Extracelulares/metabolismo , Trampas Extracelulares/efectos de los fármacos , ADN/química , Masculino , Hidrogeles/química , Hidrogeles/farmacología , Ratas , Hemostasis/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Hemostáticos/farmacología , Hemostáticos/química , Ratas Sprague-Dawley , Hemorragia , Humanos , Neutrófilos/metabolismo , Modelos Animales de EnfermedadRESUMEN
Developing a hemostatic material suitable for rapid hemostasis remains a challenge. This study presents a novel aminated gelatin sponge cross-linked with dialdehyde starch, exhibiting excellent biocompatibility and hemostatic ability. This aminated gelatin sponge features hydrophilic surface and rich porous structure with a porosity of up to 80 %. The results show that the aminated gelatin sponges exhibit superior liquid absorption capacity and can absorb up to 30-50 times their own mass of simulated body fluid within 5 min. Compared with the commercial gelatin hemostatic sponge and non-aminated gelatin hemostatic sponge, the aminated gelatin hemostatic sponge can accelerate the hemostatic process through electrostatic interactions, demonstrating superior hemostatic performance in both in vitro and in vivo hemostasis tests. The aminated gelatin sponge can effectively control the hemostatic time within 80 s in the in vivo rat femoral artery injury model, significantly outperforming both commercial and non-aminated gelatin sponges. In addition, the aminated gelatin sponge also exhibits good biocompatibility and certain antibacterial properties. The proposed aminated gelatin sponge has very good application prospects for the management of massive hemorrhage.
Asunto(s)
Materiales Biocompatibles , Gelatina , Hemostáticos , Almidón , Animales , Almidón/química , Almidón/farmacología , Almidón/análogos & derivados , Ratas , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Hemostáticos/química , Hemostáticos/farmacología , Gelatina/química , Gelatina/farmacología , Masculino , Porosidad , Ratas Sprague-Dawley , Hemorragia/tratamiento farmacológico , Hemostasis/efectos de los fármacos , Esponja de Gelatina Absorbible/química , Esponja de Gelatina Absorbible/farmacología , Reactivos de Enlaces Cruzados/química , Arteria Femoral/efectos de los fármacos , HumanosRESUMEN
For patients with hemophilia A and high-titer inhibitors treated with bypassing agents there are no reliable methods to assess treatment effect. We investigated the utility of global hemostatic methods in assessing treatment with bypassing agents (rFVIIa or activated prothrombin complex [aPCC]). All patients with hemophilia A and inhibitors followed at the Coagulation Unit or the Pediatric Coagulation Unit at Karolinska University Hospital aged 6 years and above were eligible for this noninterventional study. Baseline plasma samples were spiked with bypassing agents in increasing concentrations (aPCC 50 U/kg, 100 U/kg, 150 U/kg, and rFVIIa 90 µg/kg and 270 µg/kg) in vitro. For patients treated with factor concentrates or bypassing agents follow-up samples were collected (in vivo tests). The samples were analyzed using overall hemostatic potential (OHP), and calibrated automated thrombogram, Calibrated Automated Thrombogram (CAT). Nine patients with hemophilia A with inhibitors were included. Spiking with rFVIIa normalized the coagulation potential in 6/8 samples, in 3 only with high dose. Only one sample did not improve adequately after spiking with aPCC. The improvement in hemostasis was reliably shown by both CAT and OHP. The baseline potential was, however, more often measurable by OHP compared to CAT. Factor concentrate had been administered to 5 patients normalizing the hemostatic potential in vivo in 2 (without spiking). The hemostatic improvement induced by spiking with rFVIIa or aPCC is shown by OHP and CAT, but the results have to be evaluated in larger cohorts.
Asunto(s)
Factor VIIa , Hemofilia A , Humanos , Hemofilia A/tratamiento farmacológico , Hemofilia A/sangre , Proyectos Piloto , Niño , Masculino , Factor VIIa/farmacología , Factor VIIa/uso terapéutico , Adolescente , Proteínas Recombinantes/uso terapéutico , Proteínas Recombinantes/farmacología , Hemostasis/efectos de los fármacos , Factores de Coagulación Sanguínea/farmacología , Factores de Coagulación Sanguínea/uso terapéutico , Hemostáticos/uso terapéutico , Hemostáticos/farmacología , Adulto , FemeninoRESUMEN
Natural and synthetic colorants present in food can modulate hemostasis, which includes the coagulation process and blood platelet activation. Some colorants have cardioprotective activity as well. However, the effect of genipin (a natural blue colorant) and synthetic blue colorants (including patent blue V and brilliant blue FCF) on hemostasis is not clear. In this study, we aimed to investigate the effects of three blue colorants-genipin, patent blue V, and brilliant blue FCF-on selected parameters of hemostasis in vitro. The anti- or pro-coagulant potential was assessed in human plasma by measuring the following coagulation times: thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (APTT). Moreover, we used the Total Thrombus formation Analysis System (T-TAS, PL-chip) to evaluate the anti-platelet potential of the colorants in whole blood. We also measured their effect on the adhesion of washed blood platelets to fibrinogen and collagen. Lastly, the cytotoxicity of the colorants against blood platelets was assessed based on the activity of extracellular lactate dehydrogenase (LDH). We observed that genipin (at all concentrations (1-200 µM)) did not have a significant effect on the coagulation times (PT, APTT, and TT). However, genipin at the highest concentration (200 µM) and patent blue V at the concentrations of 1 and 10 µM significantly prolonged the time of occlusion measured using the T-TAS, which demonstrated their anti-platelet activity. We also observed that genipin decreased the adhesion of platelets to fibrinogen and collagen. Only patent blue V and brilliant blue FCF significantly shortened the APTT (at the concentration of 10 µM) and TT (at concentrations of 1 and 10 µM), demonstrating pro-coagulant activity. These synthetic blue colorants also modulated the process of human blood platelet adhesion, stimulating the adhesion to fibrinogen and inhibiting the adhesion to collagen. The results demonstrate that genipin is not toxic. In addition, because of its ability to reduce blood platelet activation, genipin holds promise as a novel and valuable agent that improves the health of the cardiovascular system and reduces the risk of cardiovascular diseases. However, the mechanism of its anti-platelet activity remains unclear and requires further studies. Its in vivo activity and interaction with various anti-coagulant and anti-thrombotic drugs, including aspirin and its derivatives, should be examined as well.
Asunto(s)
Coagulación Sanguínea , Plaquetas , Colorantes de Alimentos , Iridoides , Humanos , Iridoides/farmacología , Coagulación Sanguínea/efectos de los fármacos , Colorantes de Alimentos/farmacología , Plaquetas/efectos de los fármacos , Plaquetas/metabolismo , Hemostasis/efectos de los fármacos , Tiempo de Tromboplastina Parcial , Adhesividad Plaquetaria/efectos de los fármacos , Fibrinógeno/metabolismo , Bencenosulfonatos/farmacología , Tiempo de Protrombina , Colorantes de Rosanilina/farmacología , Hemostáticos/farmacología , Activación Plaquetaria/efectos de los fármacos , Tiempo de TrombinaRESUMEN
Migrasomes are organelles that are generated by migrating cells. Here we report the key role of neutrophil-derived migrasomes in haemostasis. We found that a large number of neutrophil-derived migrasomes exist in the blood of mice and humans. Compared with neutrophil cell bodies and platelets, these migrasomes adsorb and enrich coagulation factors on the surface. Moreover, they are highly enriched with adhesion molecules, which enable them to preferentially accumulate at sites of injury, where they trigger platelet activation and clot formation. Depletion of neutrophils, or genetic reduction of the number of these migrasomes, significantly decreases platelet plug formation and impairs coagulation. These defects can be rescued by intravenous injection of purified neutrophil-derived migrasomes. Our study reveals neutrophil-derived migrasomes as a previously unrecognized essential component of the haemostasis system, which may shed light on the cause of various coagulation disorders and open therapeutic possibilities.
Asunto(s)
Coagulación Sanguínea , Plaquetas , Ratones Endogámicos C57BL , Neutrófilos , Neutrófilos/metabolismo , Animales , Humanos , Plaquetas/metabolismo , Ratones , Hemostasis , Movimiento Celular , Activación Plaquetaria , Masculino , Factores de Coagulación Sanguínea/metabolismo , Factores de Coagulación Sanguínea/genéticaRESUMEN
Transformation of a fibrous mat into a three-dimensional (3D) scaffold opens up abundant innovative prospects in biomedical research, particularly for studying both soft as well as hard tissues. Electrospun nanofibers, which mimic the extracellular matrix have attracted significant attention in various studies. This research focuses on rapidly converting a fibrous mat made of polycaprolactone (PCL)/pluronic F-127 (PF-127) with different percentages of monetite calcium phosphate (MCP) into desirable 3D matrix cotton using a unique gas foaming technology. These matrix cottons possess biomimetic properties and have oriented porous structures. Using this innovative technique, various shapes of 3D matrix cotton, such as squares, hollow tubes, and other customizable forms, were successfully produced. Importantly, these 3D matrix cottons showed a consistent distribution of monetite particles with total porosity ranging from 90% to 98%. The structure of the 3D matrix cotton, its water/blood absorption capacity, the potential for causing non-hemolysis, and rapid hemostatic properties were thoroughly investigated. Additionally, periodontal cells were cultured on the 3D matrix cotton to assess their viability and morphology, revealing promising results. Furthermore, a coculture study involving NIH-3T3 and MG-63 cells on the 3D matrix cotton showed spheroidal formation within 24 h. Notably, in vitro assessments indicated that the matrix cotton containing 15% monetite (PCL-MMC15%) exhibited superior absorbent capabilities, excellent cell viability, and rapid hemostatic characteristics. Subsequently, the effectiveness of PCL-MMC15% in promoting mandibular bone regeneration was evaluated through an in vivo study on rabbits using a mandibular injury model. The results demonstrated that PCL-MMC15% facilitated the resolution of defects in the mandibular region by initiating new bone formation. Therefore, the presented 3D matrix cotton (PCL-MMC15%) shows significant promise for applications in both mandibular bone regeneration and hemostasis.
Asunto(s)
Materiales Biocompatibles , Regeneración Ósea , Fibra de Algodón , Mandíbula , Poliésteres , Andamios del Tejido , Animales , Ratones , Regeneración Ósea/efectos de los fármacos , Materiales Biocompatibles/química , Andamios del Tejido/química , Poliésteres/química , Humanos , Células 3T3 NIH , Fosfatos de Calcio/química , Conejos , Porosidad , Hemostasis/efectos de los fármacos , Hemostáticos/farmacología , Hemostáticos/uso terapéutico , Hemostáticos/química , Nanofibras/químicaRESUMEN
Trauma is the leading cause of death in individuals up to 45 years of age. Alterations in platelet function are a critical component of trauma-induced coagulopathy (TIC), yet these changes and the potential resulting dysfunction is incompletely understood. The lack of clinical assays available to explore platelet function in this patient population has hindered detailed understanding of the role of platelets in TIC. The objective of this study was to assess trauma patient ex vivo flow-dependent platelet hemostatic capacity in a microfluidic model. We hypothesized that trauma patients would have flow-regime dependent alterations in platelet function. Blood was collected from trauma patients with level I activations (N = 34) within 60 min of hospital arrival, as well as healthy volunteer controls (N = 10). Samples were perfused through a microfluidic model of injury at venous and arterial shear rates, and a subset of experiments were performed after incubation with fluorescent anti-CD41 to quantify platelets. Complete blood counts were performed as well as plasma-based assays to quantify coagulation times, fibrinogen, and von Willebrand factor (VWF). Exploratory correlation analyses were employed to identify relationships with microfluidic hemostatic parameters. Trauma patients had increased microfluidic bleeding times compared to healthy controls. While trauma patient samples were able to deposit a substantial amount of clot in the model injury site, the platelet contribution to microfluidic hemostasis was attenuated. Trauma patients had largely normal hematology and plasma-based coagulation times, yet had elevated D-Dimer and VWF. Venous microfluidic bleeding time negatively correlated with VWF, D-Dimer, and mean platelet volume (MPV), while arterial microfluidic bleeding time positively correlated with oxygenation. Arterial clot growth rate negatively correlated with red cell count, and positively with mean corpuscular volume (MCV). We observed changes in clot composition in trauma patient samples reflected by significantly diminished platelet contribution, which resulted in reduced hemostatic function in a microfluidic model of vessel injury. We observed a reduction in platelet clot contribution under both venous and arterial flow ex vivo in trauma patient samples. While our population was heterogenous and had relatively mild injury severity, microfluidic hemostatic parameters correlated with different patient-specific data depending on the flow setting, indicating potentially differential mechanistic pathways contributing to platelet hemostatic capacity in the context of TIC. These data were generated with the goal of identifying key features of platelet dysfunction in bleeding trauma patients under conditions of flow and to determine if these features correlate with clinically available metrics, thus providing preliminary surrogate markers of physiological platelet dysfunction to be further studied across larger cohorts. Future studies will continue to explore those relationships and further define mechanisms of TIC and their relationship with patient outcomes.
Asunto(s)
Plaquetas , Hemostasis , Microfluídica , Heridas y Lesiones , Humanos , Plaquetas/metabolismo , Masculino , Femenino , Adulto , Heridas y Lesiones/sangre , Heridas y Lesiones/complicaciones , Microfluídica/métodos , Persona de Mediana Edad , Trastornos de la Coagulación Sanguínea/etiología , Trastornos de la Coagulación Sanguínea/sangre , Factor de von Willebrand/metabolismo , Fibrinógeno/metabolismo , Estudios de Casos y Controles , Tiempo de SangríaRESUMEN
This review rigorously investigates the early cerebral changes associated with Alzheimer's disease, which manifest long before clinical symptoms arise. It presents evidence that the dysregulation of calcium (Ca2+) homeostasis, along with mitochondrial dysfunction and aberrant autophagic processes, may drive the disease's progression during its asymptomatic, preclinical stage. Understanding the intricate molecular interplay that unfolds during this critical period offers a window into identifying novel therapeutic targets, thereby advancing the treatment of neurodegenerative disorders. The review delves into both established and emerging insights into the molecular alterations precipitated by the disruption of Ca2+ balance, setting the stage for cognitive decline and neurodegeneration.